NovoBench: Benchmarking Deep Learning-based De Novo Peptide Sequencing Methods in Proteomics

Jingbo Zhou, Shaorong Chen, Jun Xia, Sizhe Liu, Tianze Ling, Wenjie Du, Yue Liu, Jianwei Yin, Stan Z. Li·June 16, 2024

Summary

The paper "NovoBench: Benchmarking Deep Learning-based De Novo Peptide Sequencing Methods in Proteomics" addresses the need for a standardized evaluation framework in the field by introducing NovoBench. This benchmark addresses the lack of consensus datasets and limited evaluation metrics by incorporating diverse datasets (Seven-species, Nine-species, and HC-PT), integrating multiple models, and including comprehensive metrics such as precision, recall, PTM identification, efficiency, and robustness to factors like sequence length, noise, and missing fragmentation. The benchmark aims to facilitate fair comparisons, guide method development, and promote open-source research by providing a unified and reproducible platform for assessing peptide sequencing models in proteomics. The study evaluates various models, including traditional and Transformer-based approaches, and highlights the impact of different factors on their performance, with the goal of improving the accuracy and efficiency of de novo peptide sequencing.

Key findings

2

Paper digest

What problem does the paper attempt to solve? Is this a new problem?

The paper aims to address two key challenges in the field of de novo peptide sequencing using deep learning methods . The first challenge is the lack of consensus on evaluation datasets, leading to unfair comparisons between different research papers due to the use of different datasets . The second challenge involves the limitations of current methods in terms of precision and recall metrics at the amino acid or peptide level, without considering important factors like post-translational modifications (PTMs), efficiency, robustness to peptide length, noise peaks, and missing fragment ratio . These challenges are not entirely new but are significant in advancing the field of de novo peptide sequencing by highlighting the need for a unified benchmark and comprehensive evaluation metrics .


What scientific hypothesis does this paper seek to validate?

This paper aims to validate the scientific hypothesis that the development of a unified benchmark, NovoBench, for de novo peptide sequencing in proteomics can address key challenges in the field, such as the lack of consensus on evaluation datasets, limited evaluation metrics, and the need to consider influencing factors like post-translational modifications, efficiency, and robustness to various factors . The paper integrates diverse mass spectrum data, models like DeepNovo, PointNovo, Casanovo, InstaNovo, AdaNovo, and π-HelixNovo, and comprehensive evaluation metrics to provide a more thorough assessment of current de novo peptide sequencing methods .


What new ideas, methods, or models does the paper propose? What are the characteristics and advantages compared to previous methods?

The paper "NovoBench: Benchmarking Deep Learning-based De Novo Peptide Sequencing Methods in Proteomics" proposes several new ideas, methods, and models in the field of de novo peptide sequencing .

  1. Unified Benchmark NovoBench: The paper introduces NovoBench, a unified benchmark for de novo peptide sequencing that addresses the lack of consensus in evaluation datasets, enabling fair and comparable assessments of different research papers . NovoBench integrates diverse mass spectrum data, various models such as DeepNovo, PointNovo, Casanovo, InstaNovo, AdaNovo, and π-HelixNovo, and comprehensive evaluation metrics beyond traditional amino acid-level or peptide-level precision and recall .

  2. Comprehensive Evaluation Metrics: In addition to traditional metrics, the paper emphasizes the importance of evaluating models' performance in identifying post-translational modifications (PTMs), efficiency, and robustness to factors like peptide length, noise peaks, and missing fragment ratio, which are critical influencing factors often overlooked in previous studies .

  3. Deep Learning-based Models: The paper integrates various deep learning-based models for de novo peptide sequencing, such as DeepNovo, PointNovo, Casanovo, InstaNovo, AdaNovo, and π-HelixNovo, into the NovoBench framework . These models aim to improve the accuracy and efficiency of de novo peptide sequencing by leveraging deep learning techniques and addressing the challenges associated with traditional methods .

  4. Large-Scale Study and Insights: Leveraging the NovoBench benchmark, the paper conducts a large-scale study of current methods, leading to insightful findings that pave the way for future developments in the field of de novo peptide sequencing . By considering a wide range of influencing factors and performance metrics, the paper provides a comprehensive analysis of the strengths and limitations of existing models, opening up new possibilities for advancements in the field . The paper "NovoBench: Benchmarking Deep Learning-based De Novo Peptide Sequencing Methods in Proteomics" introduces several key characteristics and advantages compared to previous methods in de novo peptide sequencing .

  5. Unified Benchmark NovoBench: The paper addresses the lack of consensus in evaluation datasets by introducing NovoBench, a unified benchmark for de novo peptide sequencing. This benchmark integrates diverse mass spectrum data, various deep learning-based models, and comprehensive evaluation metrics beyond traditional amino acid-level or peptide-level precision and recall. By providing a standardized platform for evaluation, NovoBench enables fair and comparable assessments of different models, overcoming the inconsistency in datasets used by previous methods .

  6. Comprehensive Evaluation Metrics: Unlike previous works that mainly focus on amino acid-level or peptide-level precision and recall, the paper emphasizes the importance of evaluating models based on additional metrics. These include the ability to identify post-translational modifications (PTMs), efficiency, and robustness to factors like peptide length, noise peaks, and missing fragment ratio. By introducing new metrics to assess these critical abilities, NovoBench offers a more comprehensive evaluation of de novo peptide sequencing models, addressing important aspects often overlooked in previous studies .

  7. Deep Learning-based Models Integration: The paper integrates various deep learning-based models such as DeepNovo, PointNovo, Casanovo, InstaNovo, AdaNovo, and π-HelixNovo into the NovoBench framework. These models leverage deep learning techniques to enhance the accuracy and efficiency of de novo peptide sequencing, offering improved performance compared to traditional methods. By incorporating a range of advanced models, NovoBench provides researchers with a diverse set of tools for peptide sequencing tasks .

  8. Large-Scale Study and Insights: Leveraging the NovoBench benchmark, the paper conducts a large-scale study of current methods, leading to insightful findings that guide future developments in de novo peptide sequencing. By considering a wide range of influencing factors and performance metrics, the paper offers valuable insights into the strengths and limitations of existing models, paving the way for advancements in the field. This comprehensive analysis enables researchers to make informed decisions when selecting models for specific applications, contributing to the progress of de novo peptide sequencing .


Do any related researches exist? Who are the noteworthy researchers on this topic in this field?What is the key to the solution mentioned in the paper?

Several related research studies exist in the field of de novo peptide sequencing methods in proteomics. Noteworthy researchers in this field include Ruedi Aebersold, Matthias Mann, Vlado Danˇcík, Pavel A Pevzner, Yonathan Lissanu Deribe, Tony Pawson, Ivan Dikic, Ashok R Dongré, John R Yates, Guangyou Duan, Dirk Walther, Kevin Eloff, and many others .

The key to the solution mentioned in the paper "NovoBench: Benchmarking Deep Learning-based De Novo Peptide Sequencing Methods in Proteomics" is the development of a unified benchmark called NovoBench for de novo peptide sequencing. This benchmark integrates diverse mass spectrum data, various deep learning models, and comprehensive evaluation metrics to address the challenges faced in this important task. The benchmark aims to provide a standardized platform for evaluating the performance of different de novo peptide sequencing models, considering factors like post-translational modifications, efficiency, robustness to peptide length, noise peaks, and missing fragment ratio .


How were the experiments in the paper designed?

The experiments in the paper were designed to benchmark deep learning-based de novo peptide sequencing methods in proteomics. The experiments involved:

  • Utilizing datasets like the Nine-species dataset, Seven-species dataset, and HC-PT dataset for evaluation .
  • Training models on specific species and evaluating their performance on unseen species .
  • Incorporating diverse mass spectrum data, integrated models, and comprehensive evaluation metrics in the NovoBench framework .
  • Assessing models' abilities in identifying post-translational modifications (PTMs), efficiency, robustness to peptide length, noise peaks, and missing fragment ratio .
  • Conducting a large-scale study to compare different models in a fair manner and providing insights for future development .

What is the dataset used for quantitative evaluation? Is the code open source?

The dataset used for quantitative evaluation in the context of de novo peptide sequencing methods is the Nine-species dataset . This dataset is widely used by previous works such as DeepNovo, PointNovo, and Casanovo, and it contains high-resolution mass spectra and peptide labels from 9 different species . Additionally, the HC-PT dataset is another dataset mentioned, which includes synthetic tryptic peptides spanning all canonical human proteins and isoforms, peptides from alternative proteases, and HLA peptides . The HC-PT dataset is characterized by high-resolution spectra for human-origin peptides .

Regarding the open-source code, the context mentions that recent strong baselines in de novo peptide sequencing, such as DeepNovo, InstaNovo, PointNovo, AdaNovo, and CasaNovo, come with open-source training code . This availability of open-source training code enhances transparency and reproducibility in the field of de novo peptide sequencing .


Do the experiments and results in the paper provide good support for the scientific hypotheses that need to be verified? Please analyze.

The experiments and results presented in the paper provide strong support for the scientific hypotheses that needed verification. The paper addresses key challenges in de novo peptide sequencing, such as the lack of consensus on evaluation datasets and the limited evaluation metrics used in previous works . By developing the NovoBench benchmark, the study integrates diverse mass spectrum data, various models, and comprehensive evaluation metrics, including the identification of post-translational modifications (PTMs), efficiency, and robustness to influencing factors like peptide length, noise peaks, and missing fragments .

The paper extensively evaluates the performance of deep learning-based de novo peptide sequencing models on different datasets, such as the Seven-species, Nine-species, and HC-PT datasets, to ensure a comprehensive and accurate assessment of the models . It also highlights the importance of considering factors like peptide length, noise peaks, and missing fragments, which can significantly impact the performance of the models .

Moreover, the paper provides insights into the robustness of models concerning peptide length, showing that while longer peptides pose challenges for accurate prediction, the performance of models stabilizes beyond a certain threshold. For example, when peptide length exceeds 14, the precision of most models remains relatively stable, except for Instanovo, which exhibits poor robustness to increasing peptide length . This analysis contributes to a better understanding of how different models perform under varying conditions, supporting the scientific hypotheses and advancing the field of de novo peptide sequencing .


What are the contributions of this paper?

The paper "NovoBench: Benchmarking Deep Learning-based De Novo Peptide Sequencing Methods in Proteomics" makes several significant contributions in the field of de novo peptide sequencing:

  • Unified Benchmark Creation: The paper introduces the first unified benchmark called NovoBench for de novo peptide sequencing. This benchmark includes diverse mass spectrum data, integrated models, and comprehensive evaluation metrics .
  • Evaluation of Existing Methods: It conducts a large-scale study of current methods, such as DeepNovo, PointNovo, Casanovo, InstaNovo, AdaNovo, and π-HelixNovo, to report insightful findings that can guide future development in the field of de novo peptide sequencing .
  • Addressing Key Challenges: The paper addresses two key challenges in de novo peptide sequencing: the lack of consensus for evaluation datasets leading to unfair comparisons and the limitation of current methods to amino acid-level or peptide-level precision and recall metrics. By introducing NovoBench, it aims to overcome these challenges and provide a standardized platform for evaluating de novo peptide sequencing methods .
  • Consideration of Influencing Factors: NovoBench evaluates the models' performance not only based on amino acid-level and peptide-level precision and recall but also considers factors like identifying post-translational modifications (PTMs), efficiency, robustness to peptide length, noise peaks, and missing fragment ratio. These factors are crucial but often overlooked in existing evaluation metrics .
  • Open-Sourced Benchmark: The benchmark created in this paper will be open-sourced to facilitate future research and application in the field of de novo peptide sequencing .

What work can be continued in depth?

To further advance the field of deep learning-based de novo peptide sequencing in proteomics, several areas of work can be continued in depth based on the NovoBench benchmarking study:

  1. Standardization of Evaluation Datasets: One key area for improvement is the establishment of standardized evaluation datasets. Currently, the lack of consensus on evaluation datasets leads to challenges in comparing results across different research papers, affecting the fairness of comparisons .

  2. Enhanced Evaluation Metrics: While existing works in de novo peptide sequencing focus on metrics like peptide-level or amino acid-level precision and recall, there is a need to develop metrics that evaluate important model abilities more comprehensively. For instance, assessing the models' performance in identifying post-translational modifications (PTMs) and their efficiency and robustness to factors like peptide length, noise peaks, and missing fragment ratio can provide a more holistic evaluation .

  3. Robustness Analysis: Further research can delve into the robustness of models to critical influencing factors such as peptide length, noise peaks, and missing fragment ratio. Understanding how different models perform under varying conditions can help in selecting the most suitable model for specific scenarios .

  4. Automated Computational Proteomics Pipeline: Future efforts can focus on building an automated end-to-end computational proteomics pipeline. This pipeline could streamline processes related to loading PSMs data, experimental setup, and model evaluation for both de novo peptide sequencing and theoretical mass spectrum prediction, thereby facilitating scientific research and practical applications in computational proteomics .

Tables

1

Introduction
Background
Emergence of deep learning in peptide sequencing
Current challenges in evaluation and consensus datasets
Objective
To establish a standardized benchmark
Facilitate fair comparisons and method development
Promote open-source research and reproducibility
Method
Data Collection
Diverse Datasets
Seven-species dataset
Nine-species dataset
HC-PT (Human Cancer Proteome) dataset
Model Integration
Traditional approaches
Transformer-based approaches
Evaluation Metrics
Precision
Recall
PTM (Post-Translational Modification) identification
Efficiency
Robustness to sequence length, noise, and missing fragmentation
Benchmark Design
Consensus Data Creation
Selection and preprocessing of raw data
Generation of ground truth peptide sequences
Model Evaluation Protocol
Training and testing procedures
Cross-validation techniques
Model Performance Analysis
Comparative analysis of different models
Impact of various factors on model performance
Identification of trends and best practices
Reproducibility and Open-Source Component
Guidelines for replication
Availability of benchmark code and datasets
Collaboration platform for researchers
Conclusion
Summary of findings
Implications for future research and method optimization
Recommendations for the field of proteomics
Future Directions
Directions for benchmark improvement
Potential applications and extensions
Open questions and challenges remaining
Basic info
papers
quantitative methods
artificial intelligence
Advanced features
Insights
What is the primary focus of the paper "NovoBench: Benchmarking Deep Learning-based De Novo Peptide Sequencing Methods in Proteomics"?
How does the benchmark contribute to fair comparisons and method development in the field?
What datasets and metrics does NovoBench incorporate for evaluating deep learning-based peptide sequencing methods?
What problem does NovoBench aim to address in the field of proteomics?

NovoBench: Benchmarking Deep Learning-based De Novo Peptide Sequencing Methods in Proteomics

Jingbo Zhou, Shaorong Chen, Jun Xia, Sizhe Liu, Tianze Ling, Wenjie Du, Yue Liu, Jianwei Yin, Stan Z. Li·June 16, 2024

Summary

The paper "NovoBench: Benchmarking Deep Learning-based De Novo Peptide Sequencing Methods in Proteomics" addresses the need for a standardized evaluation framework in the field by introducing NovoBench. This benchmark addresses the lack of consensus datasets and limited evaluation metrics by incorporating diverse datasets (Seven-species, Nine-species, and HC-PT), integrating multiple models, and including comprehensive metrics such as precision, recall, PTM identification, efficiency, and robustness to factors like sequence length, noise, and missing fragmentation. The benchmark aims to facilitate fair comparisons, guide method development, and promote open-source research by providing a unified and reproducible platform for assessing peptide sequencing models in proteomics. The study evaluates various models, including traditional and Transformer-based approaches, and highlights the impact of different factors on their performance, with the goal of improving the accuracy and efficiency of de novo peptide sequencing.
Mind map
HC-PT (Human Cancer Proteome) dataset
Nine-species dataset
Seven-species dataset
Cross-validation techniques
Training and testing procedures
Generation of ground truth peptide sequences
Selection and preprocessing of raw data
Robustness to sequence length, noise, and missing fragmentation
Efficiency
PTM (Post-Translational Modification) identification
Recall
Precision
Transformer-based approaches
Traditional approaches
Diverse Datasets
Promote open-source research and reproducibility
Facilitate fair comparisons and method development
To establish a standardized benchmark
Current challenges in evaluation and consensus datasets
Emergence of deep learning in peptide sequencing
Open questions and challenges remaining
Potential applications and extensions
Directions for benchmark improvement
Recommendations for the field of proteomics
Implications for future research and method optimization
Summary of findings
Collaboration platform for researchers
Availability of benchmark code and datasets
Guidelines for replication
Identification of trends and best practices
Impact of various factors on model performance
Comparative analysis of different models
Model Evaluation Protocol
Consensus Data Creation
Evaluation Metrics
Model Integration
Data Collection
Objective
Background
Future Directions
Conclusion
Reproducibility and Open-Source Component
Model Performance Analysis
Benchmark Design
Method
Introduction
Outline
Introduction
Background
Emergence of deep learning in peptide sequencing
Current challenges in evaluation and consensus datasets
Objective
To establish a standardized benchmark
Facilitate fair comparisons and method development
Promote open-source research and reproducibility
Method
Data Collection
Diverse Datasets
Seven-species dataset
Nine-species dataset
HC-PT (Human Cancer Proteome) dataset
Model Integration
Traditional approaches
Transformer-based approaches
Evaluation Metrics
Precision
Recall
PTM (Post-Translational Modification) identification
Efficiency
Robustness to sequence length, noise, and missing fragmentation
Benchmark Design
Consensus Data Creation
Selection and preprocessing of raw data
Generation of ground truth peptide sequences
Model Evaluation Protocol
Training and testing procedures
Cross-validation techniques
Model Performance Analysis
Comparative analysis of different models
Impact of various factors on model performance
Identification of trends and best practices
Reproducibility and Open-Source Component
Guidelines for replication
Availability of benchmark code and datasets
Collaboration platform for researchers
Conclusion
Summary of findings
Implications for future research and method optimization
Recommendations for the field of proteomics
Future Directions
Directions for benchmark improvement
Potential applications and extensions
Open questions and challenges remaining
Key findings
2

Paper digest

What problem does the paper attempt to solve? Is this a new problem?

The paper aims to address two key challenges in the field of de novo peptide sequencing using deep learning methods . The first challenge is the lack of consensus on evaluation datasets, leading to unfair comparisons between different research papers due to the use of different datasets . The second challenge involves the limitations of current methods in terms of precision and recall metrics at the amino acid or peptide level, without considering important factors like post-translational modifications (PTMs), efficiency, robustness to peptide length, noise peaks, and missing fragment ratio . These challenges are not entirely new but are significant in advancing the field of de novo peptide sequencing by highlighting the need for a unified benchmark and comprehensive evaluation metrics .


What scientific hypothesis does this paper seek to validate?

This paper aims to validate the scientific hypothesis that the development of a unified benchmark, NovoBench, for de novo peptide sequencing in proteomics can address key challenges in the field, such as the lack of consensus on evaluation datasets, limited evaluation metrics, and the need to consider influencing factors like post-translational modifications, efficiency, and robustness to various factors . The paper integrates diverse mass spectrum data, models like DeepNovo, PointNovo, Casanovo, InstaNovo, AdaNovo, and π-HelixNovo, and comprehensive evaluation metrics to provide a more thorough assessment of current de novo peptide sequencing methods .


What new ideas, methods, or models does the paper propose? What are the characteristics and advantages compared to previous methods?

The paper "NovoBench: Benchmarking Deep Learning-based De Novo Peptide Sequencing Methods in Proteomics" proposes several new ideas, methods, and models in the field of de novo peptide sequencing .

  1. Unified Benchmark NovoBench: The paper introduces NovoBench, a unified benchmark for de novo peptide sequencing that addresses the lack of consensus in evaluation datasets, enabling fair and comparable assessments of different research papers . NovoBench integrates diverse mass spectrum data, various models such as DeepNovo, PointNovo, Casanovo, InstaNovo, AdaNovo, and π-HelixNovo, and comprehensive evaluation metrics beyond traditional amino acid-level or peptide-level precision and recall .

  2. Comprehensive Evaluation Metrics: In addition to traditional metrics, the paper emphasizes the importance of evaluating models' performance in identifying post-translational modifications (PTMs), efficiency, and robustness to factors like peptide length, noise peaks, and missing fragment ratio, which are critical influencing factors often overlooked in previous studies .

  3. Deep Learning-based Models: The paper integrates various deep learning-based models for de novo peptide sequencing, such as DeepNovo, PointNovo, Casanovo, InstaNovo, AdaNovo, and π-HelixNovo, into the NovoBench framework . These models aim to improve the accuracy and efficiency of de novo peptide sequencing by leveraging deep learning techniques and addressing the challenges associated with traditional methods .

  4. Large-Scale Study and Insights: Leveraging the NovoBench benchmark, the paper conducts a large-scale study of current methods, leading to insightful findings that pave the way for future developments in the field of de novo peptide sequencing . By considering a wide range of influencing factors and performance metrics, the paper provides a comprehensive analysis of the strengths and limitations of existing models, opening up new possibilities for advancements in the field . The paper "NovoBench: Benchmarking Deep Learning-based De Novo Peptide Sequencing Methods in Proteomics" introduces several key characteristics and advantages compared to previous methods in de novo peptide sequencing .

  5. Unified Benchmark NovoBench: The paper addresses the lack of consensus in evaluation datasets by introducing NovoBench, a unified benchmark for de novo peptide sequencing. This benchmark integrates diverse mass spectrum data, various deep learning-based models, and comprehensive evaluation metrics beyond traditional amino acid-level or peptide-level precision and recall. By providing a standardized platform for evaluation, NovoBench enables fair and comparable assessments of different models, overcoming the inconsistency in datasets used by previous methods .

  6. Comprehensive Evaluation Metrics: Unlike previous works that mainly focus on amino acid-level or peptide-level precision and recall, the paper emphasizes the importance of evaluating models based on additional metrics. These include the ability to identify post-translational modifications (PTMs), efficiency, and robustness to factors like peptide length, noise peaks, and missing fragment ratio. By introducing new metrics to assess these critical abilities, NovoBench offers a more comprehensive evaluation of de novo peptide sequencing models, addressing important aspects often overlooked in previous studies .

  7. Deep Learning-based Models Integration: The paper integrates various deep learning-based models such as DeepNovo, PointNovo, Casanovo, InstaNovo, AdaNovo, and π-HelixNovo into the NovoBench framework. These models leverage deep learning techniques to enhance the accuracy and efficiency of de novo peptide sequencing, offering improved performance compared to traditional methods. By incorporating a range of advanced models, NovoBench provides researchers with a diverse set of tools for peptide sequencing tasks .

  8. Large-Scale Study and Insights: Leveraging the NovoBench benchmark, the paper conducts a large-scale study of current methods, leading to insightful findings that guide future developments in de novo peptide sequencing. By considering a wide range of influencing factors and performance metrics, the paper offers valuable insights into the strengths and limitations of existing models, paving the way for advancements in the field. This comprehensive analysis enables researchers to make informed decisions when selecting models for specific applications, contributing to the progress of de novo peptide sequencing .


Do any related researches exist? Who are the noteworthy researchers on this topic in this field?What is the key to the solution mentioned in the paper?

Several related research studies exist in the field of de novo peptide sequencing methods in proteomics. Noteworthy researchers in this field include Ruedi Aebersold, Matthias Mann, Vlado Danˇcík, Pavel A Pevzner, Yonathan Lissanu Deribe, Tony Pawson, Ivan Dikic, Ashok R Dongré, John R Yates, Guangyou Duan, Dirk Walther, Kevin Eloff, and many others .

The key to the solution mentioned in the paper "NovoBench: Benchmarking Deep Learning-based De Novo Peptide Sequencing Methods in Proteomics" is the development of a unified benchmark called NovoBench for de novo peptide sequencing. This benchmark integrates diverse mass spectrum data, various deep learning models, and comprehensive evaluation metrics to address the challenges faced in this important task. The benchmark aims to provide a standardized platform for evaluating the performance of different de novo peptide sequencing models, considering factors like post-translational modifications, efficiency, robustness to peptide length, noise peaks, and missing fragment ratio .


How were the experiments in the paper designed?

The experiments in the paper were designed to benchmark deep learning-based de novo peptide sequencing methods in proteomics. The experiments involved:

  • Utilizing datasets like the Nine-species dataset, Seven-species dataset, and HC-PT dataset for evaluation .
  • Training models on specific species and evaluating their performance on unseen species .
  • Incorporating diverse mass spectrum data, integrated models, and comprehensive evaluation metrics in the NovoBench framework .
  • Assessing models' abilities in identifying post-translational modifications (PTMs), efficiency, robustness to peptide length, noise peaks, and missing fragment ratio .
  • Conducting a large-scale study to compare different models in a fair manner and providing insights for future development .

What is the dataset used for quantitative evaluation? Is the code open source?

The dataset used for quantitative evaluation in the context of de novo peptide sequencing methods is the Nine-species dataset . This dataset is widely used by previous works such as DeepNovo, PointNovo, and Casanovo, and it contains high-resolution mass spectra and peptide labels from 9 different species . Additionally, the HC-PT dataset is another dataset mentioned, which includes synthetic tryptic peptides spanning all canonical human proteins and isoforms, peptides from alternative proteases, and HLA peptides . The HC-PT dataset is characterized by high-resolution spectra for human-origin peptides .

Regarding the open-source code, the context mentions that recent strong baselines in de novo peptide sequencing, such as DeepNovo, InstaNovo, PointNovo, AdaNovo, and CasaNovo, come with open-source training code . This availability of open-source training code enhances transparency and reproducibility in the field of de novo peptide sequencing .


Do the experiments and results in the paper provide good support for the scientific hypotheses that need to be verified? Please analyze.

The experiments and results presented in the paper provide strong support for the scientific hypotheses that needed verification. The paper addresses key challenges in de novo peptide sequencing, such as the lack of consensus on evaluation datasets and the limited evaluation metrics used in previous works . By developing the NovoBench benchmark, the study integrates diverse mass spectrum data, various models, and comprehensive evaluation metrics, including the identification of post-translational modifications (PTMs), efficiency, and robustness to influencing factors like peptide length, noise peaks, and missing fragments .

The paper extensively evaluates the performance of deep learning-based de novo peptide sequencing models on different datasets, such as the Seven-species, Nine-species, and HC-PT datasets, to ensure a comprehensive and accurate assessment of the models . It also highlights the importance of considering factors like peptide length, noise peaks, and missing fragments, which can significantly impact the performance of the models .

Moreover, the paper provides insights into the robustness of models concerning peptide length, showing that while longer peptides pose challenges for accurate prediction, the performance of models stabilizes beyond a certain threshold. For example, when peptide length exceeds 14, the precision of most models remains relatively stable, except for Instanovo, which exhibits poor robustness to increasing peptide length . This analysis contributes to a better understanding of how different models perform under varying conditions, supporting the scientific hypotheses and advancing the field of de novo peptide sequencing .


What are the contributions of this paper?

The paper "NovoBench: Benchmarking Deep Learning-based De Novo Peptide Sequencing Methods in Proteomics" makes several significant contributions in the field of de novo peptide sequencing:

  • Unified Benchmark Creation: The paper introduces the first unified benchmark called NovoBench for de novo peptide sequencing. This benchmark includes diverse mass spectrum data, integrated models, and comprehensive evaluation metrics .
  • Evaluation of Existing Methods: It conducts a large-scale study of current methods, such as DeepNovo, PointNovo, Casanovo, InstaNovo, AdaNovo, and π-HelixNovo, to report insightful findings that can guide future development in the field of de novo peptide sequencing .
  • Addressing Key Challenges: The paper addresses two key challenges in de novo peptide sequencing: the lack of consensus for evaluation datasets leading to unfair comparisons and the limitation of current methods to amino acid-level or peptide-level precision and recall metrics. By introducing NovoBench, it aims to overcome these challenges and provide a standardized platform for evaluating de novo peptide sequencing methods .
  • Consideration of Influencing Factors: NovoBench evaluates the models' performance not only based on amino acid-level and peptide-level precision and recall but also considers factors like identifying post-translational modifications (PTMs), efficiency, robustness to peptide length, noise peaks, and missing fragment ratio. These factors are crucial but often overlooked in existing evaluation metrics .
  • Open-Sourced Benchmark: The benchmark created in this paper will be open-sourced to facilitate future research and application in the field of de novo peptide sequencing .

What work can be continued in depth?

To further advance the field of deep learning-based de novo peptide sequencing in proteomics, several areas of work can be continued in depth based on the NovoBench benchmarking study:

  1. Standardization of Evaluation Datasets: One key area for improvement is the establishment of standardized evaluation datasets. Currently, the lack of consensus on evaluation datasets leads to challenges in comparing results across different research papers, affecting the fairness of comparisons .

  2. Enhanced Evaluation Metrics: While existing works in de novo peptide sequencing focus on metrics like peptide-level or amino acid-level precision and recall, there is a need to develop metrics that evaluate important model abilities more comprehensively. For instance, assessing the models' performance in identifying post-translational modifications (PTMs) and their efficiency and robustness to factors like peptide length, noise peaks, and missing fragment ratio can provide a more holistic evaluation .

  3. Robustness Analysis: Further research can delve into the robustness of models to critical influencing factors such as peptide length, noise peaks, and missing fragment ratio. Understanding how different models perform under varying conditions can help in selecting the most suitable model for specific scenarios .

  4. Automated Computational Proteomics Pipeline: Future efforts can focus on building an automated end-to-end computational proteomics pipeline. This pipeline could streamline processes related to loading PSMs data, experimental setup, and model evaluation for both de novo peptide sequencing and theoretical mass spectrum prediction, thereby facilitating scientific research and practical applications in computational proteomics .

Tables
1
Scan the QR code to ask more questions about the paper
© 2025 Powerdrill. All rights reserved.